Markel Co. (MKL) Vice Chairman Steven A. Markel Sells 200 Shares

Markel Co. (NYSE:MKL) Vice Chairman Steven A. Markel sold 200 shares of the firm’s stock in a transaction dated Thursday, December 21st. The stock was sold at an average price of $1,132.73, for a total transaction of $226,546.00. Following the sale, the insider now directly owns 107,210 shares in the company, valued at $121,439,983.30. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Shares of Markel Co. (NYSE MKL) opened at $1,123.37 on Friday. The company has a debt-to-equity ratio of 0.28, a current ratio of 0.55 and a quick ratio of 0.55. Markel Co. has a 12-month low of $887.40 and a 12-month high of $1,157.30. The stock has a market cap of $15,605.86, a P/E ratio of 368.32 and a beta of 1.04.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Nisa Investment Advisors LLC boosted its position in shares of Markel by 16.7% in the fourth quarter. Nisa Investment Advisors LLC now owns 2,100 shares of the insurance provider’s stock worth $2,392,000 after acquiring an additional 300 shares during the last quarter. Simplex Trading LLC raised its holdings in Markel by 169.1% in the fourth quarter. Simplex Trading LLC now owns 148 shares of the insurance provider’s stock valued at $168,000 after buying an additional 93 shares during the period. Parametric Portfolio Associates LLC raised its holdings in Markel by 4.4% in the third quarter. Parametric Portfolio Associates LLC now owns 24,398 shares of the insurance provider’s stock valued at $26,057,000 after buying an additional 1,029 shares during the period. IFM Investors Pty Ltd purchased a new position in Markel in the third quarter valued at approximately $478,000. Finally, Stonebridge Capital Advisors LLC purchased a new position in Markel in the third quarter valued at approximately $219,000. 76.79% of the stock is currently owned by institutional investors and hedge funds.

MKL has been the topic of several analyst reports. Boenning Scattergood reaffirmed a “buy” rating on shares of Markel in a research note on Thursday, October 26th. SunTrust Banks reaffirmed a “hold” rating and set a $1,100.00 price target on shares of Markel in a research note on Friday, October 27th. Zacks Investment Research raised shares of Markel from a “hold” rating to a “buy” rating and set a $1,253.00 target price on the stock in a research report on Friday, January 5th. Finally, Royal Bank of Canada reissued a “hold” rating and issued a $1,050.00 target price on shares of Markel in a research report on Tuesday, October 3rd. Three equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $1,109.50.

TRADEMARK VIOLATION NOTICE: “Markel Co. (MKL) Vice Chairman Steven A. Markel Sells 200 Shares” was first reported by The Lincolnian Online and is the property of of The Lincolnian Online. If you are viewing this article on another domain, it was stolen and reposted in violation of U.S. and international trademark and copyright laws. The correct version of this article can be viewed at https://www.thelincolnianonline.com/2018/01/14/insider-selling-markel-co-mkl-vice-chairman-sells-200-shares-of-stock-2-updated-updated-updated.html.

Markel Company Profile

Markel Corporation is a financial holding company serving a range of markets. The Company’s principal business markets and underwrites specialty insurance products. It monitors and reports its ongoing underwriting operations in three segments: U.S. Insurance, International Insurance and Reinsurance. The Company, through its subsidiary Markel Ventures, Inc (Markel Ventures), owns interests in various industrial and service businesses that operate outside of the specialty insurance marketplace.

Insider Buying and Selling by Quarter for Markel (NYSE:MKL)

Receive News & Ratings for Markel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply